CD40LG and psoriasis: The increase of CD32+CD154+ platelets in psoriasis patients versus healthy controls retained the statistical significance in both cohorts (cohort 2, p = 0.041, Fig. 2f; cohort 3, p = 0.006, Supplementary Fig. 1g).